Atlas Trials

The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection

Clinical trial NCT01032655 · COMPLETED

Trial details

NCT number
NCT01032655
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2009-04-01
Primary completion
2012-03-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.